Olson Eric R 4
4 · Syros Pharmaceuticals, Inc. · Filed Jul 18, 2023
Insider Transaction Report
Form 4
Olson Eric R
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-17$3.50/sh−689$2,412→ 6,661 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 31, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.